The present invention is directed to a compound according to formula, (R<SUP>2</SUP>R<SUP>3</SUP>)-B<SUP>1</SUP>-A<SUP>1</SUP>-c(A<SUP>2</SUP>-A<SUP>3</SUP>-A<SUP>4</SUP>-A<SUP>5</SUP>-A<SUP>6</SUP>-A<SUP>7</SUP>-A<SUP>8</SUP>-A<SUP>9</SUP>)-A<SUP>10</SUP>-A<SUP>11</SUP>-A<SUP>12</SUP>-A<SUP>13</SUP>-B<SUP>2</SUP>-B<SUP>3</SUP>-R<SUP>1</SUP>, that act as ligands for one or more of the melanocortin receptors, the pharmaceutically- acceptable salts thereof, to methods of using such peptides to treat mammals and to pharmaceutical compositions useful therefore comprising said peptides.
申请公布号
WO2007008684(A2)
申请公布日期
2007.01.18
申请号
WO2006US26554
申请日期
2006.07.10
申请人
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S.;DONG, ZHENG, XIN;MOREAU, JACQUES-PIERRE